GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Innovative Pharmaceutical Biotech Ltd (HKSE:00399) » Definitions » Pre-Tax Income

Innovative Pharmaceutical Biotech (HKSE:00399) Pre-Tax Income : HK$56.18 Mil (TTM As of Sep. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Innovative Pharmaceutical Biotech Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Innovative Pharmaceutical Biotech's pretax income for the six months ended in Sep. 2023 was HK$192.58 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2023 was HK$56.18 Mil. Innovative Pharmaceutical Biotech's pretax margin was 5,167.08%.

During the past 13 years, Innovative Pharmaceutical Biotech's highest Pretax Margin was 733.01%. The lowest was -3153.82%. And the median was -1403.58%.


Innovative Pharmaceutical Biotech Pre-Tax Income Historical Data

The historical data trend for Innovative Pharmaceutical Biotech's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovative Pharmaceutical Biotech Pre-Tax Income Chart

Innovative Pharmaceutical Biotech Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -260.91 -222.46 -212.16 36.43 -254.67

Innovative Pharmaceutical Biotech Semi-Annual Data
Dec13 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 121.11 -84.68 -118.27 -136.40 192.58

Competitive Comparison of Innovative Pharmaceutical Biotech's Pre-Tax Income

For the Household & Personal Products subindustry, Innovative Pharmaceutical Biotech's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innovative Pharmaceutical Biotech's Pre-Tax Income Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Innovative Pharmaceutical Biotech's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Innovative Pharmaceutical Biotech's Pre-Tax Income falls into.



Innovative Pharmaceutical Biotech Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Innovative Pharmaceutical Biotech's Pretax Income for the fiscal year that ended in Mar. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-20.703+0+-233.969+0+0.0010000000000048
=-254.67

Innovative Pharmaceutical Biotech's Pretax Income for the quarter that ended in Sep. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-6.212+0+-131.478+0+330.267
=192.58

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$56.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innovative Pharmaceutical Biotech  (HKSE:00399) Pre-Tax Income Explanation

Innovative Pharmaceutical Biotech's Pretax Margin for the quarter that ended in Sep. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=192.577/3.727
=5,167.08%

During the past 13 years, Innovative Pharmaceutical Biotech's highest Pretax Margin was 733.01%. The lowest was -3153.82%. And the median was -1403.58%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innovative Pharmaceutical Biotech Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Innovative Pharmaceutical Biotech's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovative Pharmaceutical Biotech (HKSE:00399) Business Description

Traded in Other Exchanges
N/A
Address
168-200 Connaught Road Central, Unit No. 2111, 21st Floor, Sheung Wan, West Tower Shun Tak Centre, Hong Kong, HKG
Innovative Pharmaceutical Biotech Ltd is focused on developing an insulin product that could be administered orally. It has two primary segments of business: the research and development of pharmaceutical products and the trading of beauty products. It generates maximum revenue from trading in the beauty products segment.

Innovative Pharmaceutical Biotech (HKSE:00399) Headlines

No Headlines